Small Pharma Reports Fiscal Second Quarter 2023 Highlights
Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion...
Source: globenewswire.com
Psychedelic Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psychedelic Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.